Majid Kazmi - Concepedia

Author

Majid Kazmi

Guy's and St Thomas' NHS Foundation Trust

Also Known As

Majid A Kazmi, Majid A. Kazmi, Majid Kazmi

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation Trust King's College London University College London King's College Hospital NHS Foundation Trust Sheffield Teaching Hospitals NHS Foundation Trust

About

Majid Kazmi is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, cellular therapies, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	914
2	Cellular Therapies	5	5	902
3	Immunology	5	5	902
4	Health Sciences	2	2	480
5	Blood Transplantation	2	2	198

Majid Kazmi

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies Reuben Benjamin, Charlotte Graham, Deborah Yallop, The Lancet Hematological MalignancyCell TherapyTransplantationMedicineHematology	2020	344
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE) Basil Sharrack, Riccardo Saccardi, Tobias Alexander, Bone Marrow Transplantation Cell TherapyImmunologyImmunotherapyTranslational MedicineJoint Accreditation Committee	2019	239
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases John A. Snowden, Manuela Badoglio, Myriam Labopin, Blood Advances	2017	210
Guidelines on the diagnosis and investigation of AL amyloidosis Julian D. Gillmore, Ashutosh Wechalekar, Jenny Bird, British Journal of Haematology	2014	162
Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning Kavita Raj, Antonio Pagliuca, Kenneth F. Bradstock, Biology of Blood and Marrow Transplantation Cell TherapyImmunologyTransplantation MedicineCell Replacement TherapyHaploidentical Donors	2014	136
T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma Kirsty Thomson, Emma Morris, Don Milligan, Journal of Clinical Oncology	2010	135
Guidelines for the use of imaging in the management of patients with myeloma Andrew Chantry, Majid Kazmi, Sally F. Barrington, British Journal of Haematology	2017	127
Alternate day pomalidomide retains anti‐myeloma effect with reduced adverse events and evidence of <i>in vivo</i> immunomodulation Matthew Streetly, Kylie Gyertson, Yvonne Daniel, British Journal of Haematology	2008	126
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial Reuben Benjamin, Nitin Jain, Marcela V. Maus, The Lancet Haematology Hematological MalignancyLymphoid NeoplasiaCell TherapyMedicineImmunology	2022	121
Guidelines on the management of <scp>AL</scp> amyloidosis Ashutosh Wechalekar, Julian D. Gillmore, Jenny Bird, British Journal of Haematology	2014	116

Page 1